“We're going to Examine how the commercialization of the compound fits in with our business design at Adastra in order to placement ourselves to assistance the demand from customers for a safe offer of copyright,” stated Main executive officer Michael Forbes in the information release. The corporate told VICE News it wouldn't be commenting even